Correction
Exp. Biol. Med.
Sec. Endocrinology and Nutrition
Volume 250 - 2025 | doi: 10.3389/ebm.2025.10614
Erratum: Retraction: Pyridoxal 5′ phosphate protects islets against streptozotocin-induced beta-cell dysfunction -in vitro and in vivo
- Frontiers Media SA, Lausanne, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
EBM Editorial Office (2025) Retraction: Pyridoxal 5′ phosphate protects islets against streptozotocin-induced beta-cell dysfunction -in vitro and in vivo. Exp. Biol. Med. 249:10441. doi: 10.3389/ebm.2024.10441 In the published article, there was an error in the terminology used.A correction has been made to the second and third sentences, which previously stated the following: "Particularly, in the β-Actin band in Figure 6A, two sets of western blots appear to be duplicated if reversed horizontally. Further, in the Glut2 band in the same Figure 6A, two sets of western blots appear to be duplicated as well."The corrected sentence appears below: "Particularly, in the β-Actin bands in Figure 6A, two sets of PCR bands appear to be duplicated if reversed horizontally. Further, in the Glut2/Reg-1 bands in the same Figure 6A, two sets of bands appear to be duplicated as well."The publisher apologizes for this error. The original version of this article has been updated.
Keywords: in vitro, in vivo, pyridoxal 5' phosphate, islet-cell function, diabetes
Received: 02 Apr 2025; Accepted: 02 Apr 2025.
Copyright: © 2025 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: EBM Editorial Office, Frontiers Media SA, Lausanne, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.